dexamethasone,lenalidomide,bortezomib
Takeda,Acrotech
['determination', 'mmsm']
happy to be part of the effort for the #bmtctn #dfci determination study in myeloma! in #nejm now. mpfs 67.5 mo for vrd+asct+maint len until prog vs 46.2 mo for vrd/len w/o asct so extra 21 mo pfs in favor of asct. #nejm #mmsm #asco22 
Multiple Myeloma, Waldenstroms, Amyloidosis, CAR-T and SCT Specialist at UT Southwestern Medical Center, LLS 2015 Man of the Year (tweets are my own)